Variants within the human UGT1A1 gene are associated with irinotecan induced severely adverse reactions and hyperbilirubinemia. Intra-ethnic differences in the genetic variation and haplotypes of UGT1A1 gene have been analyzed in the present study. Relationship between the concentrations of total serum bilirubin (T-bil) and haplotype structure of UGT1A1 in healthy people were also evaluated. We genotyped five functional polymorphisms including À3279T4G and À3156G4A in the enhancer region, (TA)647 in the TATA box, and 211G4A (G71R), 686C4A (P229Q) in the exon1 region of UGT1A1 in three groups of healthy Chinese ethnic populations, consisting of 264 subjects of She origin, 539 of Han origin and 273 of Dong origin. The distribution of À3279T4G, (TA)647, 211G4A of UGT1A1 differed greatly as between the three ethnic groups. All of six haplotypes differed considerably between at least two of the three groups, which highlighted the need to analyze clinically irinotecan toxicity relevant SNPs and haplotypes in a variety of different racial groups within the Chinese population. Total bilirubin concentration in homozygous carriers of the À3279G and (TA)7 allele were significantly higher than those in heterozygous carriers or homozygous carriers of wild-type alleles. Carriers of the variant haplotypes (À3279G; À3156A; (TA)7; 211G; 686C) had higher serum T-Bil concentrations compared with the other groups. Our results indicate that heterogeneity among different ethnic populations is possibly the result of microevolution and is relevant to studies into the effect of tailored drug treatment.
Introduction
The human UGT-glucuronosyltransferase superfamily contains more than a dozen members which play important roles in catalyzing the transfer of the glucuronic acid group of uridine phosphoglucuronic acid to various endogenous and exogenous compounds and facilitate their excretion in bile or urine. 1 UGT1A1 is the major UGT1 gene product that catalyzes the glucuronidation of bilirubin. Mutations in the UGT1A1 gene would decrease the enzymatic activity and are responsible for hyperbilirubinemia.
2 UGT1A1 are also involved in the glucuronidation of many drugs. A typical example is given by irinotecan, a widely used anticancer drug. Remarkable interindividual variations in the pharmacokinetics of irinotecan, especially irinotecan-induced toxity have been reported. Irinotecaninduced toxity are due to the increased exposure to unconjugated SN-38 (7-ethyl-10-hydroxycamptothecin), an active metabolite of irinotecan. Some genetic variants in UGT1A1 gene have been observed to have lower SN-38 glucuronidation rates and greater susceptibility to irinotecan induced gastrointestinal and bone marrow toxicity. [3] [4] [5] [6] It is important that patients should be pre-screened and received reduced, safe irinotecan starting doses before treatment according to their genotypes. 7 Global studies of polymorphisms in UGT1A have shown alleles and genotypes to be unequally distributed among different ethnic human populations across the world. 4, 8, 9 In the present study, the intra-ethnic difference in allele and haolptype frequencies of polymorphisms in UGT1A1 was examined in three Chinese ethnic populations. In addition, the relationship between the concentrations of total serum bilirubin (T-bil) and haplotype structure of UGT1A1 in healthy people were evaluated.
Result
Genotype and allele frequencies of the polymorphisms Five known polymorphisms of UGT1A1 were found, including À3279T4G (UGT1A1*60), À3156G4A, (TA)647(UGT1A1*28), 211G4A(G71R, UGT1A1*6), and 686C4A(P229Q, UGT1A1*27). Genotype and allele frequencies of the UGT1A polymorphisms investigated in the three ethnic populations are described in Table 1 . In each group, the distributions of all genotypes were in HardyWeinberg equilibrium.
The data show that the allele frequency of À3279T4G, (TA) 647 and 211G4A differed greatly between different ethnic groups, while the allele frequency of À3156G4A displayed a weak difference between the Dong and She groups. The polymorphisms of À3279T4G, À3156G4A, (TA) 647 and 686C4A demonstrated a relatively lower mutation frequencies in She than that of in the Dong and Han groups.
LD and haplotype analysis Strong linkage disequilibrium (LD) was observed between the five sites in UGT1A1 ( Table 2 ). All the frequencies and Pvalues corresponding to haplotypes are shown in Table 3 . 
Intra-ethnic differences in genetic variants
Six haplotypes were found, the most common haplotypes were haplotypes 1, 2 and 3 (above 85% of all haplotypes). Significant differences exist in the haplotype frequency between at least two of the three ethnic groups (Po0.001). Interestingly, Haplotype 4 which included three activityreduced polymorphisms were much more frequent in the Dong and Han groups than in the She group.
The À3279G was always associated with À3156A (haplotypes 4, 5, 6), the 211A was always associated with (TA)6 (haplotypes 3), and the 686A allele was always associated with the (TA)7 allele (haplotypes 6). The 211A was never found coexistent with (TA)6.
T-bil level assay
As showed in the Table 4 , the mean T-Bil concentrations in homozygous carriers of the À3279G and (TA)7 were significantly higher than those in heterozygous carriers or homozygous carriers of wild-type alleles. T-Bil level in the homozygous carriers of À3156A was higher than heterozygous carriers or wild-type homozygous carriers though no statistically significant difference was found. No significantly difference was found between heterozygous carriers of 211A and wild-type homozygous carriers. T-Bil level in the heterozygous carriers of 686A was higher than its homozygous carriers of wild-type alleles.
When analyzed according to their diplotypes, significant differences in the mean T-Bil concentration among the groups were found (Table 5 ). Heterozygous carriers of the variant haplotypes (À3279G; À3156A; (TA)7; 211G; 686C) had increased serum T-Bil concentrations compared with the other groups.
Discussion
Among genetic variants of UGT1A1 genes, the most extensively studied is a polymorphic (TA)n repeat in the TATA box. Significant associations between patients with the (TA)7 allele and Gilbert's syndrome as well as irinotecan induced bone marrow toxicity have been shown in several studies. Previous study has suggested that homozygosity for the (TA)7 allele occurs in 10-25% of the populations of Africa and the Indian subcontinent, and occurs at a much lower frequency in Southeast Asia. 9 In the present study, homozygosity for the (TA)7 allele was found only in 0.78% 
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A Zhang et al of all the ethnic Chinese groups. The frequency of (TA)7 allele in Han groups was identical to the frequency found in another Chinese groups. 10 The (TA)7 allele of the She group was much lower than that observed in the other two ethnic groups. Two variants of À3279T4G and the À3156G4A in the UGT1A1 enhancer region, and two nonsynonymous polymorphisms of 211G4A and 686C4A in exon1 were also associated with decreased enzyme activity for SN-38 glucuronidation. 5, 6 The À3279 T4G in the UGT1A1 enhancer was very common (39.7%), while the À3156G4A variant was registered only 12.4% compared to 30% reported in a Japanese study. 11 The 211G4A (G71R) was found at a frequency of 14.8% over the combined groups, which is consistent with the frequency of 13-23% found in other Asian populations. 10, 12, 13 The variant 686C4A was very rare in all the ethnic groups, with a frequency varying from 0.9 to 2.2%, similar to previous data. 10, 11 Strong LD was found between the five polymorphisms but with lower r 2 values except for between À3156G4A and (TA)647 (r 2 ¼ 0.88) which is consistent with a recent study. 10 Association between increased serum T-Bil levels and genetic variants of UGT1A1 was reported in healthy Koreans and Taiwanese.
14,15 A significant correlation between SN-38 and bilirubin glucuronidation has been found, high serum T-Bil concentration seemed to be a reasonably good predictor of lower irinotecan clean rate. [16] [17] [18] In the present study, the (TA)7 allele was significantly associated with higher T-Bil concentrations, in line with previous reports. 15, 19 However, different to Koreans, no association between 211A allele and bilirubin level was found. Carriers of the haplotypes 4 (À3279G; À3156A; (TA)7; 211G; 686C) had increased serum T-Bil concentrations compared with the other groups. The haplotype 4 was found to include three activity-reduced polymorphisms (À3279G, À3156 A, (TA)7). Frequency of haplotype 4 in Dong groups (12.1%) was much lower than that of in Caucasians (29.5%) and was about three times than in the She group. It is likely, therefore, that co-occurrence of those variant alleles would result in severely reduced UGT1A1 enzymatic activity, and consequently, more seriously decreased SN-38 glucuronidation ability. The high occurrence of haplotype 4 in the Han and Dong ethnic groups indicated a higher risk for irinotecan induced adverse reactions than that of She ethnic group.
Pharmacogenomic studies have revealed that ethnicity influence drug response. There are more than 50 ethnic groups in China. Each of these racial groups derived of a common origin with a unique genetic background and had a sense of group identity in economic and social organization. The Han population is the largest ethnic group in China accounting for almost 92% of the population, while the She (about 0.7million people, in the 2000 census) and Dong (about 2.9 million people, in the 2000 census) constitute two important ethnic minorities. Both allele and haplotype frequency and specific allele differences have been observed between the three ethnic populations. Mutation frequencies of UGT1A1 were much lower in She groups than that of in the Dong and Han groups. The variation in allele frequencies between the three ethnic populations is likely to be a result of different propensities for disease resistance as well as dietary preferences throughout the course of microevolution.
In conclusion, genetic differences of UGT1A1 in ethnic groups may provide pointers for tailored irinotecan treatment. Certainly, further studies on more minorities are needed to expand the present results.
Materials and methods

Study population
Samples were recruited from three Chinese ethnic groups consisting of She (n ¼ 264; 129 male and 135 female; mean age 44.8714.6 years), Han (n ¼ 539; 310 male and 229 female; mean age 43.9714.7 years) and Dong (n ¼ 273; 135 male and 137 female; mean age 49.2713.3 years). All the participants were healthy, unrelated and provided written informed consent. Fasting venous blood samples from 260 subjectes were taken for biochemical analysis, and the levels of total serum bilirubin (T-Bil) were measured. The study protocol was approved by the Ethics Committee of Shanghai Jiao Tong University.
Isolation of genomic DNA and genotype of UGT1A1 Genomic DNA samples were prepared from leukocytes contained in whole blood using the QiaAmp isolation system (Qiagen, Basel, Switzerland).
We directly sequenced the whole exon 1 region and part of the promoter region of UGT1A1. PCR was carried out on a thermal cycler (GeneAmp 9700, Applied Biosystems, Foster City, CA, USA) with a final reaction volume of 10 ml containing 5 ng genome DNA and 0.5 U Taq (Qiagen, Basel, Switzerland), 0.24 mM of each primer, and 0.2 mM deoxynucleotide triphosphates. The Cycling protocol began with a first stage of 941C for 3 min, followed by 14 cycles of 941C for 20 s, 641C for 20 s (declines 0.51C after each cycle), and Diplotypes with assignment probability (o0.9) were removed from the assignment.
Intra-ethnic differences in genetic variants 721C for 50 s, then 25 cycles of 941C for 20 s, 561C for 20 s, and 721C for 50 s, and a final extension at 721C for 5 min. The PCR products were purified by incubation with 0.15 U Shrimp alkaline phosphatase (Roche, Basel, Switzerland) and 0.75 U exonuclease 1 (New England Biolabs, Beverly, MA, USA ) at 371C for 45 min, followed by heated inactivation at 801C for 15 min. The products were then sequenced using an ABI BigDye Terminator Cycle Sequencing Kit (Perkin-Elmer Applied Biosystems, Foster City, CA, USA) on an ABI 3100 DNA sequencer (Applied Biosystems). Primers used for PCR are described in Table 6 .
Statistic analysis
Differences in allele distributions were calculated using the CLUMP program version 2.2. Odds Radio with 95% confidence intervals were calculated on http://www.hutchon.freeserve.co.uk/ConfidOR.htm. Hardy-Weinberg equilibrium calculations were made on http://www.kursus.kvl.dk/ shares/vetgen/Popgen/genetik/applets/kitest.htm, LD between two loci, denoted as D 0 , were estimated on a twolocus LD calculator (2LD) and EMLD software (http:// request.mdacc.tmc.edu/~qhuang/Software/pub.htm). The ignificance limit was set at Po0.05. Haplotypes and diplotypes were estimated by Phase (version 2.02). 20, 21 The differences in the serum T-Bil, classified according to different UGT1A1 genotypes and diaplotypes, were calculated using ANOVA. 
